top of page

Platform/Pipeline

Many cHBV treatments claim a “functional cure,” however this cure is only accessible with chronic or repeat administration(s). Conversely, HBVtech’s approach aims to provide a “lasting cure” with a single administration. 

​

HBVtech’s proprietary Gene Therapy platform is designed with the goal of achieving a lasting cure for several chronic infections (shown in pipeline chart) through a single injection. 
 

HBVt pipeline.png

HBVZ10: A Closer Look

HBVZ10, our lead candidate, has the potential to transform chronic HBV infections (cHBV), currently managed with chronic/repeat treatments, into a lasting cure with a single administration. 

​

Read our FCOI document.

bottom of page